Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography

NCT05998525 is registered in ClinicalTrials.gov with Hilda Elizabeth Macías Cervantes as lead sponsor.

NCT NCT05998525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05998525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography
Lead sponsor
Hilda Elizabeth Macías Cervantes
Phase
Phase 3
Overall status
Completed
Start date
June 21, 2021
Completion date
June 1, 2023
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete type 2, diabetes mellitus, type 2, myocardial infarction, unstable angina